AI to predict Cancer metastasis using Ultra-Echo-Sono imaging
Cancer metastasis is the leading cause of death within tumor disease and is currently an unmet clinical need. This dramatic clinical evidence requires immediate action in terms of early diagnosis and then pre-emptive therapies, no...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PTQ2020-010990
VALIDACIÓN CLÍNICA Y ANALÍTICA DE UN TEST DE DETECCIÓN TEMPR...
38K€
Cerrado
TED2021-131300B-I00
DIAGNOSTICO NO INVASIVO DE PACIENTES CON CANCER MEDIANTE INT...
187K€
Cerrado
GRANITE
Integrated AI Diagnostics in Breast Cancer
164K€
Cerrado
PID2019-103899RB-I00
BIOSENSORES PARA DESENTRAÑAR EL LEGADO Y EL FUTURO DE LA EPI...
206K€
Cerrado
TED2021-131248B-I00
ALGORITMOS DE APRENDIZAJE PROFUNDO EN EL DIAGNOSTICO DE ADEN...
280K€
Cerrado
PDC2022-133383-I00
PLATAFORMA POTENCIADA POR IA PARA EL DIAGNOSTICO DE SUBTIPOS...
129K€
Cerrado
Información proyecto AI CUrES
Duración del proyecto: 21 meses
Fecha Inicio: 2022-07-14
Fecha Fin: 2024-04-30
Líder del proyecto
POLITECNICO DI TORINO
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
150K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cancer metastasis is the leading cause of death within tumor disease and is currently an unmet clinical need. This dramatic clinical evidence requires immediate action in terms of early diagnosis and then pre-emptive therapies, not only for the primary tumor, but especially at the first stages of metastasis formation. Metastasis is the result of a complex mechanism, still under study, which involves the trafficking of biological materials, in particular extracellular vesicles (EVs), from the primary tumor site towards other tissues.
The project AI CUrES aims to propose novel methodologies for early diagnosis of metastasis, by gaining new knowledge at the early stage of their formation with a real-time and predictive approach. This work has the future vision of predicting possible patient’s outcomes and helping to set timely pre-emptive therapies. I believe that this is possible by exploiting the EVs specifically produced by the primary tumor, here by colorectal cancer (CRC). In AI CUrES, such EVs will be tagged by specific nanosized-contrast agents and their trafficking in biological media reported by an innovative multi-modal bioimaging technology having high resolution, deep tissue penetration, real-time and molecular characteristics. The collected images of EVs trafficking towards recipient cells or tissues will be refined and further elaborated by artificial intelligence algorithms, with the aim to predict the possible metastasis development from a starting CRC tumor mass.
AI CuRES will prove the efficacy of this approach by enabling, as expected outcomes, deep scientific knowledge on metastasis formation mechanisms and demonstrating a breakthrough innovation in bioimaging technologies and digital tools for health monitoring and diagnosis of oncological patients. The results can be also useful in other tumors leading to metastasis and to empower Europe towards digital tools for predictive diagnosis.